-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
LumiraDx Limited (NASDAQ:LMDX) Sees Large Increase in Short Interest
LumiraDx Limited (NASDAQ:LMDX) Sees Large Increase in Short Interest
LumiraDx Limited (NASDAQ:LMDX – Get Rating) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 309,800 shares, a growth of 14.7% from the October 31st total of 270,100 shares. Approximately 2.1% of the company's stock are short sold. Based on an average daily volume of 337,500 shares, the days-to-cover ratio is currently 0.9 days.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on LMDX shares. Raymond James decreased their price objective on LumiraDx from $4.00 to $3.50 and set an "outperform" rating for the company in a report on Friday, November 11th. BTIG Research decreased their price objective on LumiraDx from $7.00 to $4.00 and set a "buy" rating for the company in a report on Friday, August 19th.
Get LumiraDx alerts:LumiraDx Price Performance
Shares of NASDAQ LMDX opened at $1.29 on Friday. The stock has a market capitalization of $58.36 million, a price-to-earnings ratio of -0.91 and a beta of 1.05. The business has a 50-day moving average of $1.09 and a 200-day moving average of $1.88. The company has a debt-to-equity ratio of 20.12, a current ratio of 2.91 and a quick ratio of 1.63. LumiraDx has a fifty-two week low of $0.77 and a fifty-two week high of $10.42.
Hedge Funds Weigh In On LumiraDx
Hedge funds have recently modified their holdings of the stock. Bill & Melinda Gates Foundation bought a new position in LumiraDx during the third quarter worth about $14,600,000. Senvest Management LLC grew its holdings in LumiraDx by 297.0% during the third quarter. Senvest Management LLC now owns 10,737,651 shares of the company's stock worth $10,952,000 after purchasing an additional 8,032,616 shares during the period. Balyasny Asset Management LLC grew its holdings in LumiraDx by 36,072.9% during the third quarter. Balyasny Asset Management LLC now owns 3,771,385 shares of the company's stock worth $3,847,000 after purchasing an additional 3,760,959 shares during the period. Pictet Asset Management SA bought a new position in LumiraDx during the third quarter worth about $1,659,000. Finally, Colony Group LLC bought a new position in LumiraDx during the second quarter worth about $787,000.LumiraDx Company Profile
(Get Rating)
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care.
Read More
- Get a free copy of the StockNews.com research report on LumiraDx (LMDX)
- Why CSL Ltd Stock Could Be Worth a Look
- MarketBeat: Week in Review 11/28 – 12/02
- Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
Receive News & Ratings for LumiraDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LumiraDx and related companies with MarketBeat.com's FREE daily email newsletter.
LumiraDx Limited (NASDAQ:LMDX – Get Rating) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 309,800 shares, a growth of 14.7% from the October 31st total of 270,100 shares. Approximately 2.1% of the company's stock are short sold. Based on an average daily volume of 337,500 shares, the days-to-cover ratio is currently 0.9 days.
LumiraDx Limited(納斯達克:LMDX-GET評級)是11月份空頭股數大幅增長的接受者。截至11月15日,空頭股數共有309,800股,較10月31日的270,100股增長14.7%。該公司約有2.1%的股票被賣空。根據日均成交量337,500股計算,目前天數與回補比率為0.9天。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
Several equities analysts have recently weighed in on LMDX shares. Raymond James decreased their price objective on LumiraDx from $4.00 to $3.50 and set an "outperform" rating for the company in a report on Friday, November 11th. BTIG Research decreased their price objective on LumiraDx from $7.00 to $4.00 and set a "buy" rating for the company in a report on Friday, August 19th.
幾位股票分析師最近紛紛買入LMDX的股票。雷蒙德·詹姆斯在11月11日星期五的一份報告中將LumiraDx的目標價從4.00美元下調至3.50美元,併為該公司設定了“跑贏大盤”的評級。BTIG Research將LumiraDx的目標價從7.00美元下調至4.00美元,並在8月19日星期五的一份報告中為該公司設定了買入評級。
LumiraDx Price Performance
LumiraDx性價比
Shares of NASDAQ LMDX opened at $1.29 on Friday. The stock has a market capitalization of $58.36 million, a price-to-earnings ratio of -0.91 and a beta of 1.05. The business has a 50-day moving average of $1.09 and a 200-day moving average of $1.88. The company has a debt-to-equity ratio of 20.12, a current ratio of 2.91 and a quick ratio of 1.63. LumiraDx has a fifty-two week low of $0.77 and a fifty-two week high of $10.42.
上週五,納斯達克LMDX的股價開盤報1.29美元。該股市值為5,836萬美元,市盈率為-0.91,貝塔係數為1.05。該業務的50日移動均線切入位在1.09美元,200日移動均線切入位在1.88美元。該公司的債務權益比為20.12,流動比率為2.91,速動比率為1.63。LumiraDx的52周低點為0.77美元,52周高位為10.42美元。
Hedge Funds Weigh In On LumiraDx
對衝基金參與LumiraDx
LumiraDx Company Profile
LumiraDx公司簡介
(Get Rating)
(獲取評級)
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care.
LumiraDx有限公司是一家醫療診斷公司。該公司專注於通過向醫療保健提供者提供關鍵診斷信息來轉變基於社區的醫療保健。它製造和銷售一種診斷平臺,該平臺支持各種測試,在護理點具有實驗室可比的性能。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on LumiraDx (LMDX)
- Why CSL Ltd Stock Could Be Worth a Look
- MarketBeat: Week in Review 11/28 – 12/02
- Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
- Institutions Are Buying Ambarella, Should You?
- Can ZIM Defy Broad Downturn In The Container Shipping Industry?
- 免費獲取StockNews.com在LumiraDx(LMDX)上的研究報告
- 為什麼CSL有限公司的股票值得一看
- MarketBeat:回顧一週11/28-12/02
- Okta Inc.慶祝收益節節攀升,但他們能持續這種提振嗎?
- 機構正在購買安巴雷拉,你應該嗎?
- ZIM能否抵禦集裝箱航運業的普遍低迷?
Receive News & Ratings for LumiraDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LumiraDx and related companies with MarketBeat.com's FREE daily email newsletter.
接收LumiraDx日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對LumiraDx和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧